What the EU is trying to do with this trade agreement is effectively slowly poison the production of affordable generic medicines in India, which has helped keep so many people alive. This trade agreement could target us as treatment providers, simply for buying generic medicines from India to treat patients in our programs.

Piero Gandini
Head of Mission for MSF in India

India has been called the “pharmacy of the developing world” because it produces a large number of high-quality, affordable generic medicines. MSF and other treatment providers also rely on Indian generic medicines to treat other diseases and conditions.

However, a free trade agreement (FTA) currently under negotiation between the European Union (EU) and India could greatly restrict the ability of Indian generic manufacturers to continue producing high-quality, affordable medicines that millions of people with HIV/AIDS and other diseases and conditions rely on to stay alive.

To learn more about the protests and the issue at hand read this briefing on the situation.

For more information also check out MSF’s Access Campaign website.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s